Advancing Breakthroughs in Cancer Research
Advances in cell analysis, genomics, metabolic studies, protein profiling, and pathology are revealing new connections in our understanding of cancer and a comprehensive picture. From new understandings of tumor genomic microheterogeneity, to powerful and precise therapies such as immune checkpoint inhibitors. It’s an exciting time to be researching breakthroughs that could affect many lives. Whether your early discovery research, clinical trials or diagnostic tools development, Agilent is there to support scientists with an integrated portfolio of solutions.
Agilent Press Presentation at AACR
-
For additional information on the content of this presentation, or to connect with any of the presenters contact Naomi Goumillout at naomi.goumillout@agilent.com
View presentation (pdf)
Agilent Press Conference Presenters
-
Todd Christian - Vice President and General Manager, Cell Analysis Division, Agilent Technologies
Roddy O’Connor - BSc, MS, Ph.D., Research Assistant Professor of Pathology & Laboratory Medicine, Perelman School of Medicine, U. Pennsylvania
Pradipta Ghosh - M.D., Professor, Medicine and Cellular and Molecular Medicine, UC San Diego
San Diego Zoo Wildlife Alliance
-
The San Diego Zoo in California is a renowned zoological park, dedicated to conservation efforts, education, and public engagement related to wildlife and endangered species. The San Diego Zoo Wildlife Alliance utilizes flow cytometry instruments from Agilent in their research. Flow cytometry is a powerful technique used for analyzing and sorting cells based on their physical and chemical properties. It allows researchers to examine individual cells, assess cell populations, and study various biological processes.
Next Generation Solutions for Cell Therapies
-
Explore solutions for cell engineering, immunophenotyping, and high-throughput screening of optimal engineered immune cells. The success of cell therapies depends on selective engineering of immune cells followed by extensive ex-vivo characterization to identify the optimal candidate.
Next Generation Solutions Featured at AACR 2024
-
-
Agilent NovoCyte Opteon Spectral Flow Cytometer
The Agilent NovoCyte Opteon Spectral Flow Cytometer, is an advanced solution in spectral flow cytometry. This user-friendly system allows simultaneous analysis of multiple markers and offers flexibility in designing multiple marker panels. With configurations ranging from 3 to 5 lasers and support for up to 70 high-quality detectors, the NovoCyte Opteon promises enhanced research capabilities for scientists and researchers.
-
Agilent Avida
Agilent Avida's new cutting-edge target enrichment solutions enable simultaneous DNA and methylation profiling from a single sample. The proprietary Avida technology maintains original sample quality and quantity, supporting advanced applications such as liquid biopsy and multiomics capabilities for targeted next-generation sequencing (NGS). Researchers gain accelerated access to genetic and epigenetic data from limited samples, propelling cancer biology and clinical insights. The high-performance and streamlined workflows offer outstanding fidelity, turnaround time, and ease of use.
-
Agilent SureSelect Cancer Custom panels
Agilent SureSelect Cancer Custom panels offer the ability to add new and emerging biomarkers, including tumor mutational burden (TMB) and microsatellite instability (MSI), to custom tumor genomic profiling assays. These custom NGS cancer panels are designed quickly and easily using Agilent SureDesign 8.0, an intuitive probe design software powered by machine learning. These custom cancer panels extend the SureSelect Cancer product portfolio and underscore Agilent’s commitment to advancing precision oncology.
-
Agilent SureSelect CD CiberMed Tissue and SureSelect CD CiberMed Heme panels
Agilent announces a new partnership with CiberMed. This company aims to simplify cellular profiling and biomarker discovery with its digital cytometry software, iSort. The new Agilent SureSelect CD CiberMed Tissue and SureSelect CD CiberMed Heme panels enable a combined SureSelect and iSort workflow to offer a cellular profiling solution from bulk RNA-Seq data with enhanced sensitivity, accuracy, and robustness.
- URL coming soon
-
Agilent Cancer Research Solutions
-
-
Cell Analysis
Investigate dynamic cancer cell strategies with innovative cell analysis technologies.
-
-
-
Genomics
Agilent’s cancer genomic research solutions provide accurate data, insights, and enhanced productivity while improving your ability to deliver trusted answers to your critical challenges.
-
-
-
Biomarkers
Precision medicine has created a need for new cancer biomarkers for sample stratification, compound response, biobanked tissue, and disease understanding.
-
-
-
Diagnostics
Agilent builds on 50+ years of experience and cutting-edge diagnostic research to ensure a precisely calibrated assay for each companion therapy.
-
-
-
Companion Diagnostics
Agilent's pharmDx solution is a portfolio of all-in-one pharmDx kits that lead to optimal diagnostic results within companion diagnostics.
-
-
-
Biologics
Improve efficiency and increase confidence in biopharmaceutical discovery and development.
-